Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1444 (LINC01444)
- Target
- LINC01444
- Molecular classification
- Long non-coding RNA (lncRNA), Intergenic non-protein coding RNA, RNA gene
01
Overview
Long intergenic non-protein coding RNA 1444 (LINC01444) is a member of the lncRNA family, which comprises non-protein coding transcripts that often function in transcriptional and epigenetic regulation. LINC01444 has been identified as part of multigene diagnostic and risk signatures in cancer, suggesting relevance for disease biomarker development and possible therapeutic targeting. Its specific molecular functions and direct disease mechanisms remain largely unexplored, but its inclusion in tumor microenvironment regulatory signatures implies a role in cancer biology[1][4]. There are currently no documented drugs that interact directly with LINC01444, and its roles in biological pathways and protein interactions are still under investigation.
- Other names
- LINC01444Long intergenic non-protein coding RNA 1444
02
Mechanism of action
Not directly elucidated for LINC01444; possible mechanisms for drugs targeting lncRNAs include modulation of gene-expression profiles or interference with lncRNA-protein interactions, as shown for similar lncRNAs
03
Biological functions
Regulation of gene expressionImmunological modulation of the tumor microenvironmentPotential involvement in cellular processes linked to cancer progression (inferred by analogy to functionally similar lincRNAs)
04
Disease associations
Cancer (as a risk biomarker, and likely direct involvement inferred from its inclusion in prognostic signatures)
05
Safety considerations
None specifically reported for LINC01444. In general, targeting lncRNAs in therapy may pose risks due to involvement in multiple regulatory networks and potential for off-target effects.
06
Biomarkers
LINC01444 is included in *cancer risk signatures* (e.g., in nine-lncRNAs or six-lncRNAs diagnostic signatures for specific tumor types), so its expression may serve as a biomarker for cancer risk stratification or prognosis
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1444 (LINC01444).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1444 (LINC01444).